Wells Fargo’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$918K Buy
78,772
+7,797
+11% +$90.8K ﹤0.01% 3407
2025
Q1
$527K Buy
70,975
+1,689
+2% +$12.5K ﹤0.01% 3641
2024
Q4
$415K Buy
69,286
+14,807
+27% +$88.8K ﹤0.01% 3850
2024
Q3
$279K Buy
54,479
+667
+1% +$3.42K ﹤0.01% 3981
2024
Q2
$195K Buy
53,812
+15,289
+40% +$55.3K ﹤0.01% 4173
2024
Q1
$124K Buy
38,523
+4,145
+12% +$13.3K ﹤0.01% 4406
2023
Q4
$168K Buy
34,378
+6,933
+25% +$34K ﹤0.01% 4181
2023
Q3
$150K Sell
27,445
-22,372
-45% -$122K ﹤0.01% 4213
2023
Q2
$334K Buy
49,817
+16,547
+50% +$111K ﹤0.01% 4023
2023
Q1
$294K Buy
33,270
+9,214
+38% +$81.4K ﹤0.01% 3945
2022
Q4
$184K Sell
24,056
-816
-3% -$6.23K ﹤0.01% 3947
2022
Q3
$178K Sell
24,872
-10,052
-29% -$71.9K ﹤0.01% 4032
2022
Q2
$283K Sell
34,924
-679
-2% -$5.5K ﹤0.01% 3861
2022
Q1
$493K Buy
35,603
+12,088
+51% +$167K ﹤0.01% 4143
2021
Q4
$660K Sell
23,515
-3,376
-13% -$94.8K ﹤0.01% 4163
2021
Q3
$915K Sell
26,891
-8,450
-24% -$288K ﹤0.01% 4066
2021
Q2
$1.44M Sell
35,341
-781,117
-96% -$31.9M ﹤0.01% 3755
2021
Q1
$32.9M Sell
816,458
-521,369
-39% -$21M 0.01% 1266
2020
Q4
$79.1M Buy
1,337,827
+234,854
+21% +$13.9M 0.02% 742
2020
Q3
$53.6M Buy
1,102,973
+191,746
+21% +$9.32M 0.01% 828
2020
Q2
$44.1M Buy
911,227
+26,293
+3% +$1.27M 0.01% 904
2020
Q1
$24.6M Buy
884,934
+666,308
+305% +$18.5M 0.01% 1123
2019
Q4
$6.54M Buy
218,626
+3,858
+2% +$115K ﹤0.01% 2313
2019
Q3
$6.64M Buy
214,768
+109,969
+105% +$3.4M ﹤0.01% 2281
2019
Q2
$5.06M Buy
+104,799
New +$5.06M ﹤0.01% 2547